Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

Severe Psoriasis – Oral Therapy with a New Retinoid

T Fredriksson, U. Pettersson · Dermatologica · 2009 · 2.7K citations

Medicine, Dermatology, Pharmacology +11

Physicians Desk Reference

Ronald A. Arky · 1994 · 2.6K citations

Business, Marketing, Product Management +11

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Etanercept as Monotherapy in Patients with Psoriasis

Craig L. Leonardi, JEROLD L. POWERS, Robert Matheson et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16